• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测形成互变异构体和离子物种的配体和受体的结合亲和力:丝裂原激活的蛋白激酶激活的蛋白激酶 2(MK2)的抑制。

Binding affinity prediction for ligands and receptors forming tautomers and ionization species: inhibition of mitogen-activated protein kinase-activated protein kinase 2 (MK2).

机构信息

Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Vermont Campus, 261 Mountain View Drive, Colchester, Vermont 05446, USA.

出版信息

J Med Chem. 2012 Mar 8;55(5):2035-47. doi: 10.1021/jm201217q. Epub 2012 Feb 17.

DOI:10.1021/jm201217q
PMID:22280316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3315360/
Abstract

Treatment of ionization and tautomerism of ligands and receptors is one of the unresolved issues in structure-based prediction of binding affinities. Our solution utilizes the thermodynamic master equation, expressing the experimentally observed association constant as the sum of products, each valid for a specific ligand-receptor species pair, consisting of the association microconstant and the fractions of the involved ligand and receptor species. The microconstants are characterized by structure-based simulations, which are run for individual species pairs. Here we incorporated the multispecies approach into the QM/MM linear response method and used it for structural correlation of published inhibition data on mitogen-activated protein kinase (MAPK)-activated protein kinase (MK2) by 66 benzothiophene and pyrrolopyridine analogues, forming up to five tautomers and seven ionization species under experimental conditions. Extensive cross-validation showed that the resulting models were stable and predictive. Inclusion of all tautomers and ionization ligand species was essential: the explained variance increased to 90% from 66% for the single-species model.

摘要

配体和受体的离解和互变异构的处理是基于结构的结合亲和力预测中未解决的问题之一。我们的解决方案利用热力学主方程,将实验观察到的结合常数表示为乘积的和,每个乘积都适用于由特定的配体-受体物种对组成,包括结合微常数和参与的配体和受体物种的分数。微常数通过基于结构的模拟来表征,这些模拟是针对各个物种对进行的。在这里,我们将多物种方法纳入到 QM/MM 线性响应方法中,并将其用于结构相关的研究,研究了发表的关于丝裂原激活的蛋白激酶(MAPK)-激活蛋白激酶(MK2)被 66 苯并噻吩和吡咯并吡啶类似物抑制的数据,在实验条件下形成了多达五个互变异构体和七个离解物种。广泛的交叉验证表明,所得模型是稳定和可预测的。包含所有互变异构体和离解配体物种是至关重要的:从单物种模型的 66%增加到 90%,解释了方差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/229f17a16f5e/jm-2011-01217q_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/bc91b23d0af3/jm-2011-01217q_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/588d94351d36/jm-2011-01217q_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/d08cd8b8798a/jm-2011-01217q_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/8c38cfbf98dd/jm-2011-01217q_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/c794b18a7c4e/jm-2011-01217q_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/442d427e9570/jm-2011-01217q_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/229f17a16f5e/jm-2011-01217q_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/bc91b23d0af3/jm-2011-01217q_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/588d94351d36/jm-2011-01217q_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/d08cd8b8798a/jm-2011-01217q_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/8c38cfbf98dd/jm-2011-01217q_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/c794b18a7c4e/jm-2011-01217q_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/442d427e9570/jm-2011-01217q_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebbc/3315360/229f17a16f5e/jm-2011-01217q_0011.jpg

相似文献

1
Binding affinity prediction for ligands and receptors forming tautomers and ionization species: inhibition of mitogen-activated protein kinase-activated protein kinase 2 (MK2).预测形成互变异构体和离子物种的配体和受体的结合亲和力:丝裂原激活的蛋白激酶激活的蛋白激酶 2(MK2)的抑制。
J Med Chem. 2012 Mar 8;55(5):2035-47. doi: 10.1021/jm201217q. Epub 2012 Feb 17.
2
Rigorous incorporation of tautomers, ionization species, and different binding modes into ligand-based and receptor-based 3D-QSAR methods.将互变异构体、离子物种和不同结合模式严格纳入基于配体和基于受体的 3D-QSAR 方法中。
Curr Pharm Des. 2013;19(23):4316-22. doi: 10.2174/1381612811319230013.
3
Assessment of the putative binding conformation of a pyrazolopyridine class of inhibitors of MAPKAPK2 using computational studies.使用计算研究评估 MAPKAPK2 抑制剂的吡唑并吡啶类化合物的假定结合构象。
Eur J Med Chem. 2010 Jan;45(1):98-105. doi: 10.1016/j.ejmech.2009.09.030. Epub 2009 Sep 30.
4
Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).丝裂原活化蛋白激酶激活的蛋白激酶2(MK-2)的吡咯并吡啶抑制剂
J Med Chem. 2007 May 31;50(11):2647-54. doi: 10.1021/jm0611004. Epub 2007 May 5.
5
Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies.使用三维定量构效关系(3D QSAR)和对接研究对咔啉衍生物作为丝裂原活化蛋白激酶激活蛋白激酶2(MAPKAP K2)抑制剂进行结构分析。
J Chem Inf Model. 2009 Jan;49(1):53-67. doi: 10.1021/ci800294y.
6
Structural analysis of an MK2-inhibitor complex: insight into the regulation of the secondary structure of the Gly-rich loop by TEI-I01800.一种MK2抑制剂复合物的结构分析:TEI-I01800对富含甘氨酸环二级结构调控的见解。
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):80-7. doi: 10.1107/S0907444909046411. Epub 2009 Dec 21.
7
Rigorous treatment of multispecies multimode ligand-receptor interactions in 3D-QSAR: CoMFA analysis of thyroxine analogs binding to transthyretin.在 3D-QSAR 中严格处理多物种多模式配体-受体相互作用:甲状腺素类似物与转甲状腺素蛋白结合的 CoMFA 分析。
J Chem Inf Model. 2011 May 23;51(5):1132-50. doi: 10.1021/ci200055s. Epub 2011 Apr 8.
8
Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting.丝裂原活化蛋白激酶激活的蛋白激酶 2 在神经炎症、热休克蛋白 27 磷酸化和细胞周期中的作用和靶点。
Mol Pharmacol. 2014 Feb;85(2):345-56. doi: 10.1124/mol.113.090365. Epub 2013 Dec 2.
9
Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring.使用分子对接和MM-GBSA评分准确预测一系列激酶抑制剂成员的相对效力。
J Med Chem. 2006 Aug 10;49(16):4805-8. doi: 10.1021/jm060522a.
10
MK2: a novel molecular target for anti-inflammatory therapy.MK2:抗炎治疗的新型分子靶点。
Expert Opin Ther Targets. 2008 Aug;12(8):921-36. doi: 10.1517/14728222.12.8.921.

引用本文的文献

1
QDπ: A Quantum Deep Potential Interaction Model for Drug Discovery.QDπ:一种用于药物发现的量子深度学习势能交互模型。
J Chem Theory Comput. 2023 Feb 28;19(4):1261-1275. doi: 10.1021/acs.jctc.2c01172. Epub 2023 Jan 25.
2
Thermochemical and Quantum Descriptor Calculations for Gaining Insight into Ricin Toxin A (RTA) Inhibitors.用于深入了解蓖麻毒素A(RTA)抑制剂的热化学和量子描述符计算
ACS Omega. 2021 Mar 23;6(13):8764-8777. doi: 10.1021/acsomega.0c02588. eCollection 2021 Apr 6.
3
QSAR Development for Plasma Protein Binding: Influence of the Ionization State.

本文引用的文献

1
Combining Quantum Mechanics Methods with Molecular Mechanics Methods in ONIOM.在 ONIOM 中将量子力学方法与分子力学方法相结合。
J Chem Theory Comput. 2006 May;2(3):815-26. doi: 10.1021/ct050289g.
2
Constant pH Molecular Dynamics in Explicit Solvent with λ-Dynamics.在显式溶剂中结合λ动力学的恒pH分子动力学
J Chem Theory Comput. 2011 Jun 14;7(6):1962-1978. doi: 10.1021/ct200061r. Epub 2011 Apr 25.
3
Assessing the fractions of tautomeric forms of the imidazole ring of histidine in proteins as a function of pH.评估组氨酸咪唑环的互变异构形式在蛋白质中随 pH 值变化的分数。
QSAR 开发用于血浆蛋白结合:电离状态的影响。
Pharm Res. 2018 Dec 27;36(2):28. doi: 10.1007/s11095-018-2561-8.
4
Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials.靶向丝裂原活化蛋白激酶激活的蛋白激酶2(MAPKAPK2,MK2):推动小分子抑制剂进入临床试验的药物化学研究工作
J Med Chem. 2016 Apr 28;59(8):3609-34. doi: 10.1021/acs.jmedchem.5b01457. Epub 2015 Nov 9.
5
Pharmacophore selection and redesign of non-nucleotide inhibitors of anthrax edema factor.炭疽肿胀因子非核苷酸抑制剂的药效团选择和重新设计。
Toxins (Basel). 2012 Nov 8;4(11):1288-300. doi: 10.3390/toxins4111288.
6
Rigorous incorporation of tautomers, ionization species, and different binding modes into ligand-based and receptor-based 3D-QSAR methods.将互变异构体、离子物种和不同结合模式严格纳入基于配体和基于受体的 3D-QSAR 方法中。
Curr Pharm Des. 2013;19(23):4316-22. doi: 10.2174/1381612811319230013.
Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5602-7. doi: 10.1073/pnas.1102373108. Epub 2011 Mar 21.
4
Tautomerism in drug discovery.药物研发中的互变异构现象。
J Comput Aided Mol Des. 2010 Jun;24(6-7):475-84. doi: 10.1007/s10822-010-9359-z. Epub 2010 May 20.
5
Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy.通过支架跳跃策略发现的新型 3-氨基吡唑 MK-2 抑制剂。
Bioorg Med Chem Lett. 2010 Feb 1;20(3):1293-7. doi: 10.1016/j.bmcl.2009.10.138. Epub 2009 Nov 3.
6
Benzothiophene inhibitors of MK2. Part 1: structure-activity relationships, assessments of selectivity and cellular potency.MK2的苯并噻吩抑制剂。第1部分:构效关系、选择性评估及细胞活性。
Bioorg Med Chem Lett. 2009 Aug 15;19(16):4878-81. doi: 10.1016/j.bmcl.2009.02.015. Epub 2009 Feb 8.
7
Benzothiophene inhibitors of MK2. Part 2: improvements in kinase selectivity and cell potency.MK2的苯并噻吩抑制剂。第2部分:激酶选择性和细胞活性的改进。
Bioorg Med Chem Lett. 2009 Aug 15;19(16):4882-4. doi: 10.1016/j.bmcl.2009.02.017. Epub 2009 Feb 8.
8
Promotion of rare nucleobase tautomers by metal binding.通过金属结合促进稀有核碱基互变异构体
Dalton Trans. 2009 Jun 28(24):4619-34. doi: 10.1039/b823087k. Epub 2009 Feb 23.
9
MCCE2: improving protein pKa calculations with extensive side chain rotamer sampling.MCCE2:通过广泛的侧链构象采样改进蛋白质 pKa 计算。
J Comput Chem. 2009 Nov 15;30(14):2231-47. doi: 10.1002/jcc.21222.
10
QM/MM methods for biomolecular systems.用于生物分子系统的量子力学/分子力学方法。
Angew Chem Int Ed Engl. 2009;48(7):1198-229. doi: 10.1002/anie.200802019.